Skip to content

Homoeopathic medicines in Chronic Urticaria

ROLE OF INDIVIDUALISED HOMOEOPATHIC MEDICINES IN THE TREATMENT OF CHRONIC URTICARIA IN ADULTS: A SINGLE ARM PRE-POST ASSESSMENT INTERVENTIONAL STUDY - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106128
Enrollment
38
Registered
2026-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L508- Other urticaria

Interventions

Intervention1: Individualised homoeopathic medicine.: Intervention is planned as administering indicated homeopathic remedies in centesimal potencies, as decided appropriate to the cases or condition.
Delhi pharmacy which is procured from the GMP certified company. Potency, Dosage and repetition depending upon the homoeopathic principles or upon the individual requirement of the cases. total durati

Sponsors

Renu R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants having a clinical diagnosis of chronic urticaria [23], characterized by hives or wheals lasting for more than 6 weeks. 2.Age between 18-65 years.[2] 3.Patient s taking antihistamines will be enrolled after one month of wash out period. 4.Participants of all gender, religion and socioeconomic status. 5.Participants giving written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Patients with other severe dermatological conditions, autoimmune diseases or significant co-morbidities. 2.Pregnant or lactating women. 3.Patients already undergoing homoeopathic treatment for any chronic disease for last 6 months. 4.Patients having any other uncontrolled systemic diseases and on allopathic medications and immunocompromised patients 5.Patients having any psychiatric illness. 6.Patients having any addictions and substance abuses. 7.Simultaneous participation in any other clinical trial.

Design outcomes

Primary

MeasureTime frame
comparing Urticarial activity score (UAS7) before and after treatmentTimepoint: The patient will be recorded UAS7 scoring every week. The outcome will be evaluated at the baseline, and at the end of 3rd month.

Secondary

MeasureTime frame
Urticaria Control Test (UCT)Timepoint: It will be done at baseline and at the end of third month. ;Modified Naranjo criteria for HomoeopathyTimepoint: At the end of the treatment (3rd month)

Countries

India

Contacts

Public ContactDr Pritha Halder

National Institute of Homoeopathy

drprithahalder@gmail.com9875547969

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026